Beltsville, MD, USA – REPROCELL today announced the commercial launch of StemEdit, its clinical gene editing services and new gene-edited iPSC product lines leveraging OpenCRISPR-1™, an AI-designed genome editing system licensed from Profluent (Emeryville, CA, USA). StemEdit encompasses REPROCELL’s proprietary clinical gene-editing technology and its new gene-edited iPSC lines that are ready for immediate use. These offerings combine REPROCELL’s StemRNA™ […]

Solna, Sweden – Epigenica AB announces the launch of its EpiFinder™ Analysis Service, a fully managed, high-throughput platform designed to make advanced epigenomic research faster, more accessible and highly reproducible. The EpiFinder™ Analysis Service provides comprehensive, end-to-end support by managing every step of the workflow, from study design and sample logistics to sequencing, data processing, and […]

Collaboration with Dana-Farber Cancer Institute aims to identify biomarkers linked to treatment response for the next generation of cancer therapies and to define a clinical reporting framework to power precision oncology 10x also plans to establish a CLIA-certified laboratory to enable development of future innovative diagnostic tests PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), a leader in […]

BOSTON — Today, MarathonLS announces the strategic separation of its segments into two independent organizations, Marathon LS LLC and Pacer Global LLC, under private ownership of Marathon Global Holdings effective January 1, 2026. This decision reflects the continued growth of both business segments and a shared commitment to providing greater focus, specialization, and value to customers across […]

Medical Technology Associates, LLC (MTA) is pleased to announce the acquisition of Florida Pipette Calibration, LLC (Florida Pipette).  Florida Pipette specializes in pipette calibration and repair services for medical, scientific and research facilities. Debbie Martella, president of Florida Pipette, stated, “We are thrilled to collaborate with MTA as we continue to build momentum in our […]

ARCADE, N.Y. — Purity Scientific, together with its subsidiaries GenTech Scientific and Conquer Scientific, announced the launch of a complimentary technical support line to help laboratories resolve issues with chromatography, spectrometry, and other analytical instruments. The service provides immediate, expert assistance from certified Solution Scientists at no cost to the laboratory. Any laboratory, regardless of where it […]

Vienna, Austria – Lexogen, a Vienna-based biotech company specialized in RNA transcriptomics technologies and services announces the completion of a large-scale data generation project producing comprehensive functional genomics datasets from primary human hepatocytes with Ochre Bio. The project included over 120,000 samples assessed with Lexogen’s proprietary extraction-free, high-resolution gene expression profiling platform and NGS Services. […]

IRVINE, Calif. — Zymo Research, a global leader in next-generation sequencing (NGS), has entered a strategic partnership with biomodal, an omics-based life sciences technology and analytics company. As part of biomodal’s certified provider network, Zymo Research’s NGS Services division is now authorized to deliver services using biomodal’s duet multiomics solutions, enabling researchers to access comprehensive genetic […]

ARCADE, N.Y. — Purity Scientific, together with its subsidiaries GenTech Scientific and Conquer Scientific, announced its expansion into the Boston and New England markets, providing laboratories with faster, more flexible service options for analytical instruments. The move reflects the company’s growing national footprint and commitment to serving the world’s most research-intensive life sciences region. Boston […]

Custom antibody service provides research antibodies that always work—for any target, any species PHILADELPHIA — Cell Surface Bio (CSB) announces the launch VeRSa-Select™, a custom antibody service providing scientists with unparalleled access to the highest quality antibody reagents in the industry for any protein target. These include challenging and structurally complex targets such as GPCRs and ion channels, […]